Sunday, February 03, 2019

The Lancet Digital Health



A new voice for promoting digital technologies in health practice worldwide

coverPresenting The Lancet Digital Health, a new gold Open Access journal published by The Lancet. Building on The Lancet’s tradition as an advocate for health, this monthly journal is committed to publishing high-quality original research, comment, and correspondence contributing to promoting digital technologies in health practice worldwide. By bringing together the most important advances in this multidisciplinary field, The Lancet Digital Health aspires to be the most prominent publishing venue in digital health.
The Lancet Digital Health will publish important, innovative, and practice-changing research on any topic connected with digital technology in clinical medicine, public health, and global health. We will serve the digital health, clinical, and wider health communities by promoting high-quality science and supporting the ethical use of technologies and data in practice. The Lancet Digital Health’s content will cross subject boundaries, building bridges between health professionals and researchers.
Topics include, but are not limited to:


Introducing The Lancet Digital Health

Editor-in-Chief Rupa Sarkar and Senior Editor Christina Wayman discuss the aims and scope of the new journal.

Related Content




  • ARTICLES

    Machine learning for real-time prediction of complications in critical care: a retrospective study

    The Lancet Respiratory Medicine, Vol. 6, No. 12


  • ARTICLES

    Automated psychological therapy using immersive virtual reality for treatment of fear of heights: a single-blind, parallel-group, randomised controlled trial

    The Lancet Psychiatry, Vol. 5, No. 8
    Open Access


  • REVIEW

    Artificial intelligence and computer-aided diagnosis in colonoscopy: current evidence and future directions

    The Lancet Gastroenterology & Hepatology, Vol. 4, No. 1


  • COMMENT

    What is an appropriate level of evidence for a digital health intervention?

    The Lancet, Vol. 392, No. 10165


  • EDITORIAL

    Digital oncology apps: revolution or evolution?

    The Lancet Oncology, Vol. 19, No. 8


  • CORRESPONDENCE

    Artificial intelligence for cancer-associated thrombosis risk assessment

    The Lancet Haematology, Vol. 5, No. 9


  • CORRESPONDENCE

    Precision medicine and global mental health

    The Lancet Global Health, Vol. 7, No. 1
    Open Access


  • ARTICLES

    A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study

    The Lancet Oncology, Vol. 19, No. 9


  • EDITORIAL

    Is digital medicine different?

    The Lancet, Vol. 392, No. 10142


  • PERSPECTIVES

    Rethinking the medical record

    The Lancet, Vol. 391, No. 10125

No comments:

Post a Comment